With the current pointers for receptor tests, all tumors with 1% or more of beneficial cells for ER and/or PR ought to be regarded as hormone receptor constructive, as well as sufferers are thus candidates for endocrine therapy [ninety five]. New info from recent scientific studies and systematic critiques https://patrickf219isa9.wizzardsblog.com/profile